Print Page     Close Window     

SEC Filings

8-K
SERES THERAPEUTICS, INC. filed this Form 8-K on 06/12/2017
Entire Document
 


Slide 9

Clostridium difficile Infection Overview and R&D Programs Leading the Microbiome Revolution


© Seres Therapeutics. All Rights Reserved.